BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 24743544)

  • 1. Genetic variants may play an important role in mRNA-miRNA interaction: evidence for haplotype-dependent downregulation of ABCC2 (MRP2) by miRNA-379.
    Werk AN; Bruckmueller H; Haenisch S; Cascorbi I
    Pharmacogenet Genomics; 2014 Jun; 24(6):283-91. PubMed ID: 24743544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of ABCC2 haplotypes on transcriptional and posttranscriptional gene regulation and function.
    Laechelt S; Turrini E; Ruehmkorf A; Siegmund W; Cascorbi I; Haenisch S
    Pharmacogenomics J; 2011 Feb; 11(1):25-34. PubMed ID: 20351751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ABCC2 polymorphisms and haplotype are associated with drug resistance in Chinese epileptic patients.
    Qu J; Zhou BT; Yin JY; Xu XJ; Zhao YC; Lei GH; Tang Q; Zhou HH; Liu ZQ
    CNS Neurosci Ther; 2012 Aug; 18(8):647-51. PubMed ID: 22630058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of genetic polymorphisms on intestinal expression and rifampicin-type induction of ABCC2 and on bioavailability of talinolol.
    Haenisch S; May K; Wegner D; Caliebe A; Cascorbi I; Siegmund W
    Pharmacogenet Genomics; 2008 Apr; 18(4):357-65. PubMed ID: 18334920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of genetic polymorphism in ABCC2 with hepatic multidrug resistance-associated protein 2 expression and pravastatin pharmacokinetics.
    Niemi M; Arnold KA; Backman JT; Pasanen MK; Gödtel-Armbrust U; Wojnowski L; Zanger UM; Neuvonen PJ; Eichelbaum M; Kivistö KT; Lang T
    Pharmacogenet Genomics; 2006 Nov; 16(11):801-8. PubMed ID: 17047488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of polymorphisms of ABCB1 and ABCC2 on mRNA and protein expression in normal and cancerous kidney cortex.
    Haenisch S; Zimmermann U; Dazert E; Wruck CJ; Dazert P; Siegmund W; Kroemer HK; Warzok RW; Cascorbi I
    Pharmacogenomics J; 2007 Feb; 7(1):56-65. PubMed ID: 16788565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic association analysis of transporters identifies ABCC2 loci for seizure control in women with epilepsy on first-line antiepileptic drugs.
    Grover S; Gourie-Devi M; Bala K; Sharma S; Kukreti R
    Pharmacogenet Genomics; 2012 Jun; 22(6):447-65. PubMed ID: 22565165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional characterization of ABCC2 promoter polymorphisms and allele-specific expression.
    Nguyen TD; Markova S; Liu W; Gow JM; Baldwin RM; Habashian M; Relling MV; Ratain MJ; Kroetz DL
    Pharmacogenomics J; 2013 Oct; 13(5):396-402. PubMed ID: 22664480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down-regulation of ATP-binding cassette C2 protein expression in HepG2 cells after rifampicin treatment is mediated by microRNA-379.
    Haenisch S; Laechelt S; Bruckmueller H; Werk A; Noack A; Bruhn O; Remmler C; Cascorbi I
    Mol Pharmacol; 2011 Aug; 80(2):314-20. PubMed ID: 21540293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of association between ABCC2 gene variants and treatment response in epilepsy.
    Hilger E; Reinthaler EM; Stogmann E; Hotzy C; Pataraia E; Baumgartner C; Zimprich A; Zimprich F
    Pharmacogenomics; 2012 Jan; 13(2):185-90. PubMed ID: 22256867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alternative Polyadenylation of ABC Transporters of the C-Family (ABCC1, ABCC2, ABCC3) and Implications on Posttranscriptional Micro-RNA Regulation.
    Bruhn O; Lindsay M; Wiebel F; Kaehler M; Nagel I; Böhm R; Röder C; Cascorbi I
    Mol Pharmacol; 2020 Feb; 97(2):112-122. PubMed ID: 31757862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The ABCC2 c.-24C>T polymorphism increases the risk of resistance to antiepileptic drugs: A meta-analysis.
    Qian L; Fang S; Yan YL; Zeng SS; Xu ZJ; Gong ZC
    J Clin Neurosci; 2017 Mar; 37():6-14. PubMed ID: 27816260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of ABCC2 genotype on antiepileptic drug response in Caucasian patients with childhood epilepsy.
    Ufer M; von Stülpnagel C; Muhle H; Haenisch S; Remmler C; Majed A; Plischke H; Stephani U; Kluger G; Cascorbi I
    Pharmacogenet Genomics; 2011 Oct; 21(10):624-30. PubMed ID: 21799461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic variations and haplotypes of ABCC2 encoding MRP2 in a Japanese population.
    Sai K; Saito Y; Itoda M; Fukushima-Uesaka H; Nishimaki-Mogami T; Ozawa S; Maekawa K; Kurose K; Kaniwa N; Kawamoto M; Kamatani N; Shirao K; Hamaguchi T; Yamamoto N; Kunitoh H; Ohe Y; Yamada Y; Tamura T; Yoshida T; Minami H; Matsumura Y; Ohtsu A; Saijo N; Sawada J
    Drug Metab Pharmacokinet; 2008; 23(2):139-47. PubMed ID: 18445995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of the c.3972C>T variant of the multidrug resistance-associated protein 2 Gene (MRP2/ABCC2) with susceptibility to bile duct cancer.
    Hoblinger A; Grunhage F; Sauerbruch T; Lammert F
    Digestion; 2009; 80(1):36-9. PubMed ID: 19451719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Report of new haplotype for ABCC2 gene: rs17222723 and rs8187718 in cis.
    Pratt VM; Beyer BN; Koller DL; Skaar TC; Flockhart DA; Levy KD; Vance GH
    J Mol Diagn; 2015 Mar; 17(2):201-5. PubMed ID: 25554586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ABCC2 (1249G > A) polymorphism implicates altered transport activity for sorafenib.
    Wei D; Zhang H; Peng R; Huang C; Bai R
    Xenobiotica; 2017 Nov; 47(11):1008-1014. PubMed ID: 27855531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wilson disease, ABCC2 c.3972C > T polymorphism and primary liver cancers: suggestions from a familial cluster.
    Brandi G; Rizzo A; Deserti M; Relli V; Indio V; Bin S; Pariali M; Palloni A; De Lorenzo S; Tovoli F; Tavolari S
    BMC Med Genet; 2020 Nov; 21(1):225. PubMed ID: 33208122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between ABCC2 gene haplotypes and tenofovir-induced proximal tubulopathy.
    Izzedine H; Hulot JS; Villard E; Goyenvalle C; Dominguez S; Ghosn J; Valantin MA; Lechat P; Deray AG
    J Infect Dis; 2006 Dec; 194(11):1481-91. PubMed ID: 17083032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selected ABCB1, ABCB4 and ABCC2 polymorphisms do not enhance the risk of drug-induced hepatotoxicity in a Spanish cohort.
    Ulzurrun E; Stephens C; Ruiz-Cabello F; Robles-Diaz M; Saenz-López P; Hallal H; Soriano G; Roman E; Fernandez MC; Lucena MI; Andrade RJ
    PLoS One; 2014; 9(4):e94675. PubMed ID: 24732756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.